Related Experiment Video
Updated: Jul 27, 2026

Assessing Mitochondrial Function in Sciatic Nerve by High-Resolution Respirometry
Published on: May 5, 2022
Mitochondrial involvement in schizophrenia and other functional psychoses
S A Whatley1, D Curti, R M Marchbanks
1Department of Neuroscience, Institute of Psychiatry, Denmark Hill, London, United Kingdom.
Abstract:
Gene expression has been studied in post-mortem frontal cortex samples from patients who had suffered from schizophrenia and depressive illness. mRNA was extracted and characterised by translation and separation of the products by 2D gel electrophoresis. Post-mortem artefacts and the agonal experience did not affect the size distribution or amount of specific translation products. Four expression products were specifically reduced in samples from schizophrenics compared with normals. The expression of six products was altered in affective disorder, one in common with schizophrenia, two the same as in schizophrenia but increased. cDNA libraries were produced from the mRNA samples and 5 clones present at abnormal levels in schizophrenia identified by differential screening, isolated and sequenced. All the sequences encode mitochondrial transcripts; four encode mitochondrial rRNA and one the amino acid sequence of cytochrome oxidase sub-unit II. Increased cytochrome oxidase transcripts were found in a further set of mRNA extracts from schizophrenic patients including two who had not received neuroleptic medication. The effects of neuroleptic administration as exemplified by alpha-flupenthixol compared with the ineffective beta-flupenthixol were studied in experimental animals. It was found that 13 out of 28 clones whose levels were altered were mitochondrial in origin including rRNA, COX I & II and the NADH-Q reductase. Those encoding respiratory enzymes were at abnormally low levels as a result of alpha-flupenthixol administration. Measurements of the enzymic activity of cytochrome c oxidase in post-mortem frontal cortex of schizophrenics did not indicate any differences in overall activity but there was a decreased sensitivity to azide that was abolished by neuroleptics. Studies on NADH-cytochrome c reductase showed that schizophrenics whether medicated or not had a reduced rotenone sensitive activity that was compensated for by increased rotenone insensitive activity. We conclude that changes in mitochondrial gene expression are involved in schizophrenia and probably other functional psychoses.
Insights
Mitochondrial gene expression changes, particularly involving mitochondrial ribosomal RNA and cytochrome oxidase, are implicated in schizophrenia. These alterations in gene expression were observed in post-mortem brain samples and influenced by neuroleptic medication.
Area of Science:
- Neuroscience
- Molecular Biology
- Psychiatry
Background:
- Gene expression studies in post-mortem brain tissue are crucial for understanding complex neurological disorders.
- Previous research has explored genetic and molecular alterations in schizophrenia and depressive illness, but mitochondrial involvement remains an area of active investigation.
Purpose of the Study:
- To investigate alterations in gene expression in the frontal cortex of patients with schizophrenia and depressive illness.
- To identify specific genes and pathways affected in these conditions, with a focus on mitochondrial gene products.
- To examine the influence of neuroleptic medication on mitochondrial gene expression in experimental models.
Main Methods:
- Extraction and characterization of mRNA from post-mortem frontal cortex samples.
- Differential screening of cDNA libraries to identify differentially expressed genes.
- Sequencing of identified clones to determine their genetic identity, with a focus on mitochondrial transcripts.
- Enzymatic activity assays for mitochondrial respiratory chain complexes.
Main Results:
- Four mitochondrial transcripts, including mitochondrial ribosomal RNA (rRNA) and cytochrome oxidase subunit II (COX II), were found at reduced levels in schizophrenic samples.
- Neuroleptic administration in animal models led to decreased levels of several mitochondrial transcripts, including those encoding respiratory enzymes.
- Schizophrenic patients exhibited altered NADH-cytochrome c reductase activity, with reduced rotenone-sensitive activity compensated by increased rotenone-insensitive activity.
Conclusions:
- Changes in mitochondrial gene expression are significantly involved in the pathophysiology of schizophrenia and potentially other functional psychoses.
- Mitochondrial dysfunction, particularly in respiratory chain complexes, may contribute to the neurobiological deficits observed in schizophrenia.
- Neuroleptic medications can influence mitochondrial gene expression, suggesting a complex interplay between treatment and cellular metabolism in psychosis.
Related Concept Videos
Mitochondria
Mitochondrial Membranes
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
Biological Causes of Schizophrenia
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin studies.
Psychological and Sociocultural Causes of Schizophrenia

